Medtronic plc
MDT
Kedudukan dalam Saham
#184
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Harga Saham
$94.59
Modal Pasaran
$120.99B
Perubahan (1 hari)
1.76%
Perubahan (1 tahun)
-1.39%
Negara
IE
Perdagangan Medtronic plc (MDT)
Kategori
Healthcare
Hasil untuk Medtronic plc (MDT)
Hasil pada Jan 2026 TTM: $35.48B
Menurut laporan kewangan terkini daripada Medtronic plc, hasil semasa syarikat (TTM) ialah $35.48B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $32.36B peningkatan berbanding hasil pada tahun 2023 iaitu $31.23B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Medtronic plc dari 2000 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $35.48B | 5.81% |
| 2025 | $33.54B | 3.62% |
| 2024 | $32.36B | 3.64% |
| 2023 | $31.23B | -1.45% |
| 2022 | $31.69B | 5.21% |
| 2021 | $30.12B | 4.16% |
| 2020 | $28.91B | -5.38% |
| 2019 | $30.56B | 2.02% |
| 2018 | $29.95B | 0.82% |
| 2017 | $29.71B | 3.04% |
| 2016 | $28.83B | 42.31% |
| 2015 | $20.26B | 19.15% |
| 2014 | $17.01B | 2.50% |
| 2013 | $16.59B | 2.51% |
| 2012 | $16.18B | 1.58% |
| 2011 | $15.93B | 0.73% |
| 2010 | $15.82B | 8.34% |
| 2009 | $14.60B | 8.02% |
| 2008 | $13.52B | 9.89% |
| 2007 | $12.30B | 8.92% |
| 2006 | $11.29B | 12.31% |
| 2005 | $10.05B | 10.65% |
| 2004 | $9.09B | 18.55% |
| 2003 | $7.67B | 19.57% |
| 2002 | $6.41B | 15.47% |
| 2001 | $5.55B | 10.71% |
| 2000 | $5.01B | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $46.59B | 31.28% |
US
|
|
| $25.84B | -27.19% |
US
|
|
| $21.00B | -40.83% |
US
|
|
| - | - |
DE
|
|
| $6.51B | -81.65% |
US
|
